ASGCT 2018 Election Results

ASGCT Staff - April 23, 2018

After a monthlong election, members of the American Society of Gene & Cell Therapy have elected four new members to the Society's Board of Directors, including a new incoming vice president.

Each elected member will serve a three-year term, including the incoming vice president who will enter the leadership succession line. Stephen Russell, MD, PhD will serve a yearlong term as vice president before serving as ASGCT's president-elect and, finally, president through the 2021 annual meeting.

All four of the following newly-elected members will begin their terms on the Board of Directors during the 21st Annual Meeting next month at the Hilton Chicago:

Vice President

Stephen Russell, MD, PhD
Mayo Clinic

Translational and Clinical Development Representative

Richard Morgan, PhD
bluebird bio

At-Large Director

Jennifer Adair, PhD
Fred Hutchinson Cancer Research Center

At-Large Director

Stephen Hart, PhD
UCL Great Ormond Street Institute of Child Health

Congratulations to the incoming members of the ASGCT Board of Directors!

ASGCT Policy Summit
November 4 – 6 | Washington D.C.